Pulmosis
Generic Name
Respiratory Modulator Alpha 534 mg tablet
Manufacturer
PharmaGlobal Inc.
Country
USA
Loading images...
Price Details
Current market pricing information
| Variant | Unit Price | Strip Price |
|---|---|---|
| pulmosis 534 mg tablet | ৳ 80.00 | ৳ 800.00 |
Description
Overview of the medicine
Pulmosis-534-mg-tablet is a novel respiratory modulator indicated for the management of chronic obstructive pulmonary disease (COPD) and severe asthma. It helps to improve lung function and reduce exacerbations.
Uses & Indications
Dosage
Adults
One 534 mg tablet once daily, preferably in the evening.
Elderly
No dosage adjustment typically required, but monitor for adverse effects.
Renal_impairment
No dosage adjustment needed for mild to moderate impairment; use with caution in severe impairment.
How to Take
Oral. Can be taken with or without food. Swallow the tablet whole with water; do not crush or chew.
Mechanism of Action
Pulmosis acts by selectively modulating inflammatory pathways in the airways, specifically targeting certain cytokines and chemokines involved in bronchoconstriction and mucus hypersecretion, leading to improved airflow.
Pharmacokinetics
Onset
Within 30 minutes.
Excretion
Mainly renal excretion (60%) and fecal excretion (40%).
Half life
Approximately 12-18 hours.
Absorption
Rapidly absorbed with peak plasma concentrations reached within 1-2 hours.
Metabolism
Primarily hepatic metabolism via CYP3A4.
Side Effects
Contraindications
- •Hypersensitivity to Respiratory Modulator Alpha or any component of the tablet.
- •Acute bronchospasm (not for rescue therapy).
Drug Interactions
Beta-blockers
May reduce the bronchodilatory effect. Concurrent use should be avoided unless absolutely necessary.
CYP3A4 Inhibitors
Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase plasma concentrations of Pulmosis. Monitor for increased adverse effects.
Storage
Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.
Overdose
Symptoms of overdose may include severe tremor, palpitations, tachycardia, and headache. Treatment is supportive and symptomatic.
Pregnancy & Lactation
Use in pregnancy only if the potential benefit outweighs the potential risk to the fetus. It is unknown if Pulmosis is excreted in human milk; use with caution in breastfeeding mothers.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
36 months from the date of manufacture.
Availability
Pharmacies nationwide
Approval Status
Approved by regulatory authorities
Patent Status
Under patent protection
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine
More Medicines
Explore other medicines you might be interested in
